Literature DB >> 15776783

Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus.

Naomi Creel1, Victoria Werth.   

Abstract

We describe a patient who developed rhabdomyolysis 6 weeks after starting combination therapy with hydroxychloroquine and quinacrine for the treatment of chronic cutaneous lupus erythematosus (CCLE). Myopathy due to 4-aminoquinolone antimalarials has been well documented. It is plausible that quinacrine may induce muscle injury in a manner similar to other antimalarials but, to our knowledge, rhabdomyolysis associated with antimalarial therapy has not been reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15776783

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Fatal rhabdomyolysis in systemic lupus erythematosus.

Authors:  Jozélio Freire de Carvalho; Licia Maria Henrique da Mota; Eloisa Bonfa
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 3.580

2.  Systemic lupus erythematosus presenting as hyponatremia-associated rhabdomyolysis: A case report.

Authors:  In Hee Lee; Seong Cho; Dong Jik Ahn; Min-Kyung Kim
Journal:  Medicine (Baltimore)       Date:  2021-10-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.